Furmonertinib in uncommon EGFR‐mutated non‐small cell lung cancer with central nervous system metastases: A retrospective cohort study

医学 内科学 肺癌 肿瘤科 回顾性队列研究 队列 临床终点 病理 临床试验
作者
Yuwen Xie,Hehui Fang,Wanwan Cheng,Ting Xu,Shu Xu,Chuanyong Yu,Yong Liu,Shencun Fang
出处
期刊:International Journal of Cancer [Wiley]
卷期号:157 (5): 954-963 被引量:3
标识
DOI:10.1002/ijc.35460
摘要

Uncommon EGFR mutations constitute 10%-20% of all EGFR mutations in non-small cell lung cancer (NSCLC), forming a molecularly distinct and clinically heterogeneous subgroup. This retrospective cohort study evaluated the efficacy and safety of furmonertinib in managing central nervous system (CNS) metastases among NSCLC patients with uncommon EGFR mutations (excluding exon 20 insertion variants). Thirty-one eligible patients treated at the Affiliated Brain Hospital of Nanjing Medical University between March 2022 and August 2024 were enrolled. Serial cerebrospinal fluid (CSF) samples were subjected to next-generation sequencing for circulating tumor DNA (ctDNA) profiling. Clinical endpoints included CNS objective response rate (ORR), disease control rate (DCR), intracranial progression-free survival (iPFS), overall survival (OS), and safety parameters. The cohort demonstrated a CNS ORR of 38.7% (95% CI, 21.8%-57.8%) and DCR of 64.5% (95% CI, 45.4%-80.8%), with a median iPFS of 6.97 months. Median OS remained immature at data cutoff. A total of 21 patients with leptomeningeal metastases had baseline EGFR-mutant ctDNA detected in their CSF, with ctDNA analysis indicating intracranial responses corresponded to decreased or cleared ctDNA abundance. Longitudinal CSF ctDNA monitoring in a representative case demonstrated significant temporal correlation between molecular response and radiographic/clinical improvement. The safety profile was favorable, with no grade ≥4 adverse events or treatment-related mortality. These findings suggest that furmonertinib provides clinically meaningful CNS activity with acceptable toxicity in uncommon EGFR-mutant NSCLC, particularly when integrated with CSF ctDNA dynamics as a potential pharmacodynamic biomarker. This study highlights the therapeutic implications of third-generation EGFR-TKIs in molecularly defined NSCLC subpopulations.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
罗二狗发布了新的文献求助10
1秒前
1秒前
认真绾绾完成签到,获得积分10
1秒前
1秒前
搜集达人的应助被开心德地采纳,获得10
2秒前
科研通AI65的应助被zhang采纳,获得10
2秒前
罗二狗发布了新的文献求助10
2秒前
2秒前
2秒前
2秒前
2秒前
搞怪灯泡发布了新的文献求助50
2秒前
3秒前
Liu Luke关注了科研通微信公众号
3秒前
4秒前
Li完成签到,获得积分10
4秒前
杨德凯完成签到,获得积分20
4秒前
4秒前
深情安青的应助被开心德地采纳,获得10
5秒前
Hanniewei发布了新的文献求助50
5秒前
陈昭琼完成签到 ,获得积分10
5秒前
周思发布了新的文献求助10
5秒前
dimension完成签到,获得积分10
6秒前
坚定寒松发布了新的文献求助10
6秒前
6秒前
自觉德天完成签到 ,获得积分10
7秒前
罗二狗发布了新的文献求助10
7秒前
7Wen发布了新的文献求助10
7秒前
7秒前
罗二狗发布了新的文献求助10
7秒前
Lucas的应助被要减肥的青荷采纳,获得10
8秒前
大模型的应助被开心德地采纳,获得10
8秒前
聪明的寒梅完成签到 ,获得积分10
8秒前
罗二狗发布了新的文献求助10
8秒前
罗二狗发布了新的文献求助10
8秒前
9秒前
10秒前
10秒前
科研通AI6.4的应助被zxy采纳,获得10
10秒前
乐乐的应助被Vater采纳,获得10
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8189382
求助须知:如何正确求助?哪些是违规求助? 9576691
关于积分的说明 21849410
捐赠科研通 7787318
什么是DOI,文献DOI怎么找? 3435538
关于科研通互助平台的介绍 2559748
邀请新用户注册赠送积分活动 2482509